Beta-Nerve Growth Factor in Prostate Tissue
Author Information
Author(s): AB Paul, ES Grant, FK Habib
Primary Institution: University Department of Surgery/Urology, Western General Hospital
Hypothesis
The study examines the expression and localization of beta-nerve growth factor (β-NGF) in benign and malignant human prostate tissue and its relationship to neuroendocrine differentiation.
Conclusion
The study found that β-NGF is localized to prostate epithelium, with no significant difference in concentrations between malignant and benign tissues.
Supporting Evidence
- β-NGF concentrations were not significantly different in malignant than in benign tissues.
- The presence of β-NGF mRNA transcripts was confirmed by RT-PCR.
- Western blot analysis showed a protein co-migrating with recombinant human β-NGF.
Takeaway
This study looked at a substance called beta-nerve growth factor in prostate tissue to see if it was different in healthy and cancerous samples, but it turned out to be similar in both.
Methodology
The study used reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, immunohistochemistry, and ELISA to analyze prostate tissue samples.
Limitations
The study was limited by the inability to correlate β-NGF concentrations to neuroendocrine differentiation in malignant tissues.
Participant Demographics
15 benign prostatic hyperplastic and 15 prostate cancer patients.
Statistical Information
P-Value
0.512
Statistical Significance
p=0.512
Want to read the original?
Access the complete publication on the publisher's website